SciTransfer
Expertise area

Neurodegenerative disease diagnostics

7 European H2020 organizations list this as part of their work2 as their primary capability.

Top organizations

Most active in this area

  • ORTHOKEY ITALIA SRL

    Italian medtech SME specializing in data-driven personalized knee treatment, surgical AR tools, and digital health platforms for active ageing.

    MADIA focused on magnetic diagnostic assays for neurodegenerative diseases, extending their medical device expertise beyond orthopedics.

    SMEIT8 projects
  • NORDIC BIOSCIENCE A/S

    Danish biotech SME developing blood-based biomarkers and non-invasive diagnostics for liver disease, bone disorders, and neurodegeneration.

    BBDiag project focused on blood biomarker-based diagnostic tools for early-stage Alzheimer's disease.

    SMEDK7 projects
  • UNIVERSITATSMEDIZIN ROSTOCK

    German academic medical center specializing in liver disease therapy, neurological diagnostics, and analytical mass spectrometry within large European health consortia.

    BBDiag developed blood biomarker-based diagnostic tools for early-stage Alzheimer's; CoCA studied comorbid conditions of ADHD.

    DE6 projects
  • FONDAZIONE EUROPEAN BRAIN RESEARCHINSTITUTE RITA LEVI

    Italian neuroscience foundation specializing in brain simulation, neuroinformatics, and neurodegenerative disease research within the Human Brain Project ecosystem.

    Participated in MADIA, developing magnetic diagnostic assays specifically for neurodegenerative diseases.

    IT5 projects
  • TAGWORKS PHARMACEUTICALS BV

    Dutch SME developing bio-orthogonal click chemistry tools for PET imaging, cancer therapy, and neurodegenerative disease diagnostics.

    PET-AlphaSy (2018-2022) extended their imaging expertise into Parkinson's disease diagnostics via alpha-synuclein fibril detection.

    SMENL4 projects
  • UNIVERSITY OF CONNECTICUT

    US research university contributing neuroscience diagnostics and high-energy physics expertise to European MSCA mobility collaborations.

    AUTOIGG focused on automated IgG screening for ALS and neurodegenerative diseases; NG2-cells studied neural cell roles in health and disease.

    PrimaryUS4 projects
  • YEDITEPE UNIVERSITY VAKIF

    Istanbul private university with neurodegenerative disease diagnostics expertise via automated IgG screening, astrocyte models, and MEA electrophysiology.

    AUTOIGG (2018–2023) focused on automated functional screening of IgG autoantibodies for diagnosing neurodegenerative diseases including ALS.

    PrimaryTR2 projects